女性癌症患者更年期泌尿生殖系统综合征的管理:聚焦阴道激素治疗
本文综述女性癌症患者更年期泌尿生殖系统综合征(GSM)的管理,涵盖非激素治疗(阴道保湿剂、润滑剂、盆底物理治疗、扩张器治疗、咨询)及全身和局部激素治疗,重点回顾医学学会共识推荐及局部阴道激素治疗的安全性和有效性证据,并指出管理策略因癌症类型和特征而异。
要点
- GSM影响超过半数绝经后女性,在癌症患者中更为普遍。
- 癌症治疗可导致早绝经,使GSM症状更早出现且更严重。
- 管理包括非激素治疗和局部/全身激素治疗,需根据癌症类型个体化。
核心结论
- 了解GSM认识不足和治疗不足的未满足需求,有助于为癌症女性提供安全有效的治疗以改善生活质量。
研究设计与样本
- 综述,回顾医学学会共识推荐及相关证据,重点关注局部阴道激素治疗的安全性和有效性。
主要发现
- GSM影响超过半数绝经后女性,在癌症女性中更为普遍。
- 手术、化疗、放疗和激素治疗可导致早绝经,引起更早且更严重的症状。
- 治疗包括非激素治疗(阴道保湿剂、润滑剂、盆底物理治疗、扩张器治疗、咨询)及全身和局部激素治疗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Genitourinary syndrome of menopause is a condition describing the hypoestrogenic effects on the female genitals and lower urinary tract leading to symptoms such as vaginal dryness, vulvar and vaginal burning, dyspareunia and dysuria. Genitourinary syndrome of menopause is experienced by over half of postmenopausal women, and is even more pervasive in women with cancer. Due to treatments such as surgery, chemotherapy, radiation, and hormonal therapy, women may experience early menopause resulting in earlier and more severe symptoms. Understanding the scope of this issue in female breast and gynecologic cancer survivors and identifying treatment options for this complex patient population are paramount. Tailored patient treatments include nonhormonal therapies (vaginal moisturizers, lubricants, pelvic floor physical therapy, dilator therapy, counseling), systemic and local hormonal therapies. Consensus recommendations by medical societies and associated evidence are reviewed, with emphasis on safety and efficacy of local vaginal hormonal therapies, and management variations noted depending on cancer type and characteristics. With knowledge and understanding of the unmet need associated with under-recognition and under-treatment of genitourinary syndrome of menopause, providers caring for women with cancer are in a position to improve the quality of life of their patients by providing safe and effective treatments.
引用
- Crean-Tate KK, Faubion SS, Pederson HJ, et al. Management of genitourinary syndrome of menopause in female cancer patients: a focus on vaginal hormonal therapy. Am J Obstet Gynecol. 2019. PMID: 31473229. doi:10.1016/j.ajog.2019.08.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。